NCT04801277

Brief Summary

To determine the ability of electroacupuncture on PC6 versus sham acupuncture in reducing incidence of intraoperative and postoperative nausea vomiting in parturients who underwent Caesarean delivery under spinal anaesthesia

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 7, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 16, 2021

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2021

Completed
Last Updated

March 16, 2021

Status Verified

March 1, 2021

Enrollment Period

7 months

First QC Date

December 7, 2020

Last Update Submit

March 14, 2021

Conditions

Keywords

ElectroacupunctureNausea vomitingCaesarean Delivery

Outcome Measures

Primary Outcomes (4)

  • Intraoperative nausea vomiting

    Change in incidence

    Intraoperative 2 hours

  • Postoperative nausea vomiting

    Change in incidence

    Immediate post operative

  • Postoperative nausea vomiting

    Change in incidence

    12 hours post operative

  • Postoperative nausea vomiting

    Change in incidence

    24 hours post operative

Study Arms (2)

Acupuncture on PC6 and LI4

ACTIVE COMPARATOR

Acupuncture on bilateral acupoints, that are PC6 and LI4. The pericardium meridian PC6 point (Neiguan) is defined as follows. The patient's four fingerbreadths will be placed on the medial aspect of their forearm with the edge of the 4th finger on the wrist crease. This is then subtracted from the width of the interphalangeal joint of her thumb. The point between the tendons of extensor carpi radialis and palmaris longus was the pericardium meridian PC6 point (Neiguan). The large intestine LI4 point (Hegu) located on the dorsum of the hand, between the first and second metacarpal bones, at the midpoint of the second metacarpal bone and close to its radial border.

Procedure: Electroacupuncture on acupoints vs sham points

Acupuncture on Sham acupoints

SHAM COMPARATOR

Acupuncture on bilateral non acupoints. In sham/placebo group, patient will have the acupuncture needles inserted at non-acupoint 2cm radial to PC6 and between 2nd and 3rd metacarpal bone bilaterally, superficial skin piercing (adequate depth to let patient feels needle is inserted)

Procedure: Electroacupuncture on acupoints vs sham points

Interventions

Randomized double blinded clinical trial

Acupuncture on PC6 and LI4Acupuncture on Sham acupoints

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Parturients (36-42 weeks pregnant) aged 18-45 undergoing planned for Caesarean Section.
  • American Society of Anaesthesiology class II patients only

You may not qualify if:

  • Patients with a previous history of PONV or nausea and vomiting in the preceding 24 hours
  • Patients who required emergent surgery where delay is inappropriate and can compromise mother and foetus, e.g. foetal distress, foetal bradycardia, chorioamnionitis, cord prolapse, severe preeclampsia
  • Patients with documented or known history of allergy to granisetron
  • Morbid obesity (BMI\>40) as morbid obesity patient will be not be given intrathecal morphine due to increase risk of post operative respiratory depression.
  • Patients using any antiemetic drug including dexamethasone for 24 hours prior to Caesarean section (CS)
  • Patient who had an implanted pacemaker or defibrillator device. (safety of the use of electroacupuncture on these patient is questionable)
  • Patient who received opioids prior to CS (opioid is known to have nausea and vomiting side effect)
  • Patient refusal
  • Severe preeclampsia, gestational diabetes mellitus on treatment, neurological or cardiac disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Raja Permaisuri Bainun Ipoh

Ipoh, Perak, 30450, Malaysia

RECRUITING

Related Publications (5)

  • Macario A, Weinger M, Truong P, Lee M. Which clinical anesthesia outcomes are both common and important to avoid? The perspective of a panel of expert anesthesiologists. Anesth Analg. 1999 May;88(5):1085-91. doi: 10.1097/00000539-199905000-00023.

    PMID: 10320175BACKGROUND
  • Jelting Y, Klein C, Harlander T, Eberhart L, Roewer N, Kranke P. Preventing nausea and vomiting in women undergoing regional anesthesia for cesarean section: challenges and solutions. Local Reg Anesth. 2017 Aug 9;10:83-90. doi: 10.2147/LRA.S111459. eCollection 2017.

    PMID: 28860857BACKGROUND
  • Balki M, Carvalho JC. Intraoperative nausea and vomiting during cesarean section under regional anesthesia. Int J Obstet Anesth. 2005 Jul;14(3):230-41. doi: 10.1016/j.ijoa.2004.12.004.

  • Arnberger M, Stadelmann K, Alischer P, Ponert R, Melber A, Greif R. Monitoring of neuromuscular blockade at the P6 acupuncture point reduces the incidence of postoperative nausea and vomiting. Anesthesiology. 2007 Dec;107(6):903-8. doi: 10.1097/01.anes.0000290617.98058.d9.

  • Pierre S, Benais H, Pouymayou J. Apfel's simplified score may favourably predict the risk of postoperative nausea and vomiting. Can J Anaesth. 2002 Mar;49(3):237-42. doi: 10.1007/BF03020521.

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Study Officials

  • See Yun Chan

    Hospital Raja Permaisuri Bainun Ipoh

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized double blinded
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Obstetric Anaesthesiologist and acupuncturist

Study Record Dates

First Submitted

December 7, 2020

First Posted

March 16, 2021

Study Start

September 1, 2020

Primary Completion

March 31, 2021

Study Completion

April 30, 2021

Last Updated

March 16, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Study Methodology

Locations